Exam 4 - Watts Schizophrenia Flashcards

1
Q

positive Sx of schoziphrenia
-things we can’t normally see

A

hallucinations
delusions
bizarre behavior
thought disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

negative Sx of schizophrenia
-things we can see

A

blunted emotion
poor self care
social withdrawal
poverty in speech

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

In which do we see more of a response in treatment, negative sx or positive sx?

A

positive sx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

drugs that can exacerbate psychosis via glutamate hypothesis

A

ketamine
phencyclidine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

what is the major excitatory neurotransmitter?

A

glutamate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

drugs that can exacerbate schizophrenia sx via dopamine hypothesis

A

L-DOPA
amphetamine
bromocriptine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

which receptor that drugs act on, D1 or D2, shows great correlation between binding potency and clinical effectiveness?

A

D2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

roles of presynaptic terminals at synapse

A

safety switches for synthesis and release of dopamine
-normally, if there is too much dopamine, it leaks around the synapse and binds to presynaptic terminal to tell it to stop producing dopamine. If we block these, dopamine will continue to be synthesized and released into the synapse, causing schizophrenia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

actions of D2 antagonists in CNS on basal ganglia

A

motor effects and EPS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

actions of D2 antagonists in CNS on mesolimbic (most important)

A

primary therapeutic effects happen here

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

actions of D2 antagonists in CNS on mesocortical

A

hypofunction in schizophrenia, antagonists may exacerbate cognitive deficits

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

how common is EPS (%) and name its 4 Sx

A

30-50% of pts
increased muscle tone (dystonia)
muscle rigidity (pseudoparkinsonism)
restlessness (akathisia)
tremor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Tx of EPS (7 agents)

A

benztropine (Cogentin)
trihexyphenynidyl (Artane)
akineton (Biperiden)
anticholinergic agents
diphenhydramine
amantadine (Symmetrel) (DA releasing agent)
propranolol (for akathisia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

how common is tardive dyskinesia (%) and name its 4 Sx

A

20-40% (irreversible)
mouth: involuntary movements
choriform: irregular purposelessness
athetoid: worm like
axial hyperkinesias: to and fro movements

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Tx of tardive dyskinesia

A

Prevention!! - use least risky agent at lowest dose
newer antipsychotics (atypical)
use VMAT inhibitors
-valbenazine (Ingrezza)
-deutetrabenazine (Austedo)
remove anticholinergics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

NMS Sx

A

EPS w/ fever
impaired cognition
muscle rigidity

17
Q

Tx of NMS

A

dc drug
DA agonists, diazepam, or dantrolene

18
Q

pimozide indication(s)

A

tourette’s

19
Q

2 meds with increased risk for metabolic problems and diabetes

A

clozapine and olanzapine

20
Q

pathway involved in movement

A

nigrostriatal (NS)

21
Q

postsynaptic D2 blocking in NS pathway leads to what

A

movement disorders (typical antipsychotics)

22
Q

blocking presynaptic serotonin receptors leads to what

A

increase in synaptic DA

23
Q

describe atypical antipsychotic blocking in NS synapse

A

blocks serotonin receptors, which increases synaptic DA
drug competes with DA at D2 receptors which leads to less motor SE

24
Q

clozapine (Clozaril) SE

A

agranulocytosis
anticholinergic properties
antihistamine properties

25
Q

olanzapine (Zyprexa) SE

A

weight gain
risk of diabetes

26
Q

risperidone (Risperidal) SE

A

low EPS at <8mg/day
weight gain

27
Q

lurasidone (Latuda) SE

A

less weight gain and metabolic effects
fast onset (just days)

28
Q

antiadrenergic SE

A

bradycardia
hypotension
hyperglycemia

29
Q

aripiprazole (Abilify) SE

A

weight gain
low risk for motor SE
partial agonist

30
Q

low dopaminergic activity = ?

A

EPS

31
Q

high dopaminergic activity = ?

A

psychosis

32
Q

brexpiprazole (Rexulti) SE

A

less akathisia than aripiprazole

33
Q

cariprazine (Vraylar) SE

A

high risk of akathisia

34
Q

quetiapine (Seroquel) SE

A

hypotension
sedation (lower risk)